Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) Income from Non-Controlling Interests (2024 - 2026)

Usana Health Sciences has reported Income from Non-Controlling Interests over the past 3 years, most recently at -$556000.0 for Q2 2026.

  • Quarterly Income from Non-Controlling Interests fell 396.43% to -$556000.0 in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $273000.0 through Apr 2026, up 432.93% year-over-year, with the annual reading at $717000.0 for FY2026, 2290.0% up from the prior year.
  • Income from Non-Controlling Interests was -$556000.0 for Q2 2026 at Usana Health Sciences, down from $180000.0 in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $789000.0 in Q2 2025 and troughed at -$556000.0 in Q2 2026.
  • The 3-year median for Income from Non-Controlling Interests is -$41000.0 (2024), against an average of $31833.3.
  • The largest YoY upside for Income from Non-Controlling Interests was 500.0% in 2026 against a maximum downside of 396.43% in 2026.
  • A 3-year view of Income from Non-Controlling Interests shows it stood at $30000.0 in 2024, then crashed by 566.67% to -$140000.0 in 2025, then crashed by 297.14% to -$556000.0 in 2026.
  • Per Business Quant, the three most recent readings for USNA's Income from Non-Controlling Interests are -$556000.0 (Q2 2026), $180000.0 (Q1 2026), and -$140000.0 (Q3 2025).